Tag: antibody drug

AstraZeneca’s COVID-19 Prevention Jab Granted Emergency Authorization for Immune Compromised

The U.S. Food and Drug Administration (FDA) on Dec. 8 issued an emergency use authorization for an AstraZeneca COVID-19 antibody drug designed to help prevent infection in people with compromised immune systems. The drug, called Evusheld, is a combination of two long-acting synthetic antibodies: tixagevimab and cilgavimab, which are derived from B-cells donated by patients who have recovered from the…


FDA Grants Eli Lilly’s Experimental COVID-19 Antibody-Drug Emergency Use Authorization

Eli Lilly’s COVID-19 antibody-drug has been granted emergency use authorization by the Food and Drug Administration (FDA), widening access to a therapy that has shown improvement in treating patients with mild to moderate cases of the CCP virus. Data from a late-stage trial last month showed that Eli Lilly’s combination therapy of two antibodies, bamlanivimab and…